Browse 515 colorectal cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 515
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Halifax, Montreal, Toronto, Calgary, Vancouver
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT06960291
Recruiting
ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
for
Liver Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05062317
Phase2, Recruiting
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
for
Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05195710
Phase1, Recruiting
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 25+
Code: NCT05420064
Recruiting
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
for
Solid Tumor, HNSCC, RCC, CRC
Location: Jacksonville FL, Rochester MN, Scottsdale AZ,
Sponsor: SparX Biotech(Jiangsu) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06259552
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Boston MA, Lake Success NY, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
New
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
for
Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8,
Location: New Orleans LA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07551596
Phase2, Recruiting
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
for
Colorectal Cancer Metastatic
Location: Newport Beach CA, Los Angeles CA
Sponsor: Buzzard Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06634875
Phase2, Recruiting
Increasing Colorectal Cancer Screening in African Americans
for
Colorectal Cancer
Location: Philadelphia PA
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Sex: All
Age: 50 - 70+
Code: NCT00893295
Phase3, Recruiting
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
for
Colorectal Cancer
Location: Washington DC
Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Sex: All
Age: 18+
Code: NCT00895323
Phase1, Recruiting
Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer
for
Colorectal Cancer
Location: Redlands CA
Sponsor: Loma Linda Oncology Medical Group, Inc.
Sex: All
Age: 18+
Code: NCT00967655
Phase2, Recruiting
Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial
for
Colorectal Cancer
Location: Atlanta GA
Sponsor: Morehouse School of Medicine
Sex: All
Age: 50 - 70+
Code: NCT01805622
Recruiting
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies